These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 30215731

  • 1. Can Placental Corticotropin-Releasing Hormone Inform Timing of Antenatal Corticosteroid Administration?
    Swales DA, Grande LA, Wing DA, Edelmann M, Glynn LM, Sandman C, Smith R, Bowman M, Davis EP.
    J Clin Endocrinol Metab; 2019 Feb 01; 104(2):443-450. PubMed ID: 30215731
    [Abstract] [Full Text] [Related]

  • 2. Patterns of use and optimal timing of antenatal corticosteroids in twin compared with singleton pregnancies.
    Rottenstreich A, Levin G, Kleinstern G, Haj Yahya R, Rottenstreich M, Yagel S, Elchalal U.
    Acta Obstet Gynecol Scand; 2018 Dec 01; 97(12):1508-1514. PubMed ID: 30098014
    [Abstract] [Full Text] [Related]

  • 3. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM, Garland JS, Stafeil BR, Carr MH, Peckman GS, Pircon RA.
    Am J Obstet Gynecol; 2007 May 01; 196(5):457.e1-6. PubMed ID: 17466700
    [Abstract] [Full Text] [Related]

  • 4. Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial.
    Crowther CA, Ashwood P, Andersen CC, Middleton PF, Tran T, Doyle LW, Robinson JS, Harding JE, ASTEROID Study Group.
    Lancet Child Adolesc Health; 2019 Nov 01; 3(11):769-780. PubMed ID: 31523039
    [Abstract] [Full Text] [Related]

  • 5. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks.
    Jobe AH, Goldenberg RL.
    Am J Obstet Gynecol; 2018 Jul 01; 219(1):62-74. PubMed ID: 29630886
    [Abstract] [Full Text] [Related]

  • 6. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.
    Crowther CA, Haslam RR, Hiller JE, Doyle LW, Robinson JS, Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group.
    Lancet; 2006 Jun 10; 367(9526):1913-9. PubMed ID: 16765760
    [Abstract] [Full Text] [Related]

  • 7. Low levels of corticotropin-releasing hormone during early pregnancy are associated with precocious maturation of the human fetus.
    Class QA, Buss C, Davis EP, Gierczak M, Pattillo C, Chicz-DeMet A, Sandman CA.
    Dev Neurosci; 2008 Jun 10; 30(6):419-26. PubMed ID: 19127063
    [Abstract] [Full Text] [Related]

  • 8. Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE).
    Schmitz T, Alberti C, Ursino M, Baud O, Aupiais C, BETADOSE study group and the GROG (Groupe de Recherche en Gynécologie Obstétrique).
    BMC Pregnancy Childbirth; 2019 Feb 12; 19(1):67. PubMed ID: 30755164
    [Abstract] [Full Text] [Related]

  • 9. The duration of fetal antenatal steroid exposure determines the durability of preterm ovine lung maturation.
    Kemp MW, Saito M, Schmidt AF, Usuda H, Watanabe S, Sato S, Hanita T, Kumagai Y, Takahashi T, Musk GC, Furfaro L, Stinson L, Fee EL, Eddershaw PJ, Payne MS, Smallwood K, Bridges J, Newnham JP, Jobe AH.
    Am J Obstet Gynecol; 2020 Feb 12; 222(2):183.e1-183.e9. PubMed ID: 31494126
    [Abstract] [Full Text] [Related]

  • 10. Influence of the interval between antenatal corticosteroid therapy and delivery on respiratory distress syndrome.
    Yasuhi I, Myoga M, Suga S, Sugimi S, Umezaki Y, Fukuda M, Yamashita H, Kusuda N.
    J Obstet Gynaecol Res; 2017 Mar 12; 43(3):486-491. PubMed ID: 28026890
    [Abstract] [Full Text] [Related]

  • 11. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: Replaces SMFM Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
    Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.orgSociety for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA. pubs@smfm.org., Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS.
    Am J Obstet Gynecol; 2021 Nov 12; 225(5):B36-B42. PubMed ID: 34363784
    [Abstract] [Full Text] [Related]

  • 12. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
    Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH.
    Am J Obstet Gynecol; 2016 Oct 12; 215(4):423-30. PubMed ID: 27342043
    [Abstract] [Full Text] [Related]

  • 13. Comparison between two doses of betamethasone administration with 12 hours vs. 24 hours intervals on prevention of respiratory distress syndrome: a randomised trial.
    Kashanian M, Eshraghi N, Sheikhansari N, Bordbar A, Khatami E.
    J Obstet Gynaecol; 2018 Aug 12; 38(6):770-776. PubMed ID: 29526138
    [Abstract] [Full Text] [Related]

  • 14. Structural and transcriptomic response to antenatal corticosteroids in an Erk3-null mouse model of respiratory distress.
    Pew BK, Harris RA, Sbrana E, Guaman MC, Shope C, Chen R, Meloche S, Aagaard K.
    Am J Obstet Gynecol; 2016 Sep 12; 215(3):384.e1-384.e89. PubMed ID: 27143398
    [Abstract] [Full Text] [Related]

  • 15. The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy.
    Kemp MW, Saito M, Usuda H, Watanabe S, Sato S, Hanita T, Kumagai Y, Molloy TJ, Clarke M, Eddershaw PJ, Musk GC, Schmidt A, Ireland D, Furfaro L, Payne MS, Newnham JP, Jobe AH.
    Am J Obstet Gynecol; 2018 Sep 12; 219(3):301.e1-301.e16. PubMed ID: 29758177
    [Abstract] [Full Text] [Related]

  • 16. Effect of betamethasone in vivo on placental corticotropin-releasing hormone in human pregnancy.
    Marinoni E, Korebrits C, Di Iorio R, Cosmi EV, Challis JR.
    Am J Obstet Gynecol; 1998 Apr 12; 178(4):770-8. PubMed ID: 9579442
    [Abstract] [Full Text] [Related]

  • 17. Prenatal phthalate exposure in relation to placental corticotropin releasing hormone (pCRH) in the CANDLE cohort.
    Barrett ES, Corsetti M, Day D, Thurston SW, Loftus CT, Karr CJ, Kannan K, LeWinn KZ, Smith AK, Smith R, Tylavsky FA, Bush NR, Sathyanarayana S.
    Environ Int; 2022 Feb 12; 160():107078. PubMed ID: 35007898
    [Abstract] [Full Text] [Related]

  • 18. Committee Opinion No.677: Antenatal Corticosteroid Therapy for Fetal Maturation.
    American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice, Society for Maternal– Fetal Medicine.
    Obstet Gynecol; 2016 Oct 12; 128(4):e187-94. PubMed ID: 27661658
    [Abstract] [Full Text] [Related]

  • 19. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.
    Wadhwa PD, Garite TJ, Porto M, Glynn L, Chicz-DeMet A, Dunkel-Schetter C, Sandman CA.
    Am J Obstet Gynecol; 2004 Oct 12; 191(4):1063-9. PubMed ID: 15507922
    [Abstract] [Full Text] [Related]

  • 20. [Antenatal corticosteroids and incidence of neonatal respiratory distress after elective caesarean section in late preterm and term neonates].
    de la Huerga López A, Sendarrubias Alonso M, Jiménez Jiménez AP, Matías Del Pozo V, Álvarez Colomo C, Muñoz Moreno MF.
    An Pediatr (Engl Ed); 2019 Dec 12; 91(6):371-377. PubMed ID: 30665860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.